Related Experiment Video
Updated: Feb 15, 2026
Conscious and Non-conscious Representations of Emotional Faces in Asperger's Syndrome
Published on: July 31, 2016
Gorlin Syndrome
I Palacios-Álvarez1, R González-Sarmiento2, E Fernández-López3
1Departamento de Dermatología, Clínica Universidad de Navarra, Pamplona, España.
Abstract:
Gorlin syndrome is a rare autosomal dominant disease caused by mutations in the sonic hedgehog signaling pathway. Of particular importance is the PTCH1 gene. The disease is characterized by the development of multiple basal cell carcinomas at young ages. These tumors may present with other skin manifestations such as palmoplantar pits and with extracutaneous manifestations such as odontogenic keratocysts and medulloblastoma. Although the dermatologist may be key for recognizing clinical suspicion of the syndrome, a multidisciplinary team is usually necessary for diagnosis, treatment, and follow-up. Skin treatment may be complicated due to the large number of basal cell carcinomas and the extent of involvement. In recent years, new drugs that inhibit targets in the sonic hedgehog pathway have been developed. Although these agents appear promising options for patients with Gorlin syndrome, their efficacy is limited by adverse effects and the development of resistance.
Insights
Gorlin syndrome, a genetic disorder affecting the sonic hedgehog pathway, causes numerous basal cell carcinomas and other tumors. New pathway-inhibiting drugs show promise but face challenges with side effects and resistance.
Area of Science:
- Genetics
- Oncology
- Dermatology
Background:
- Gorlin syndrome is a rare autosomal dominant disorder.
- It involves mutations in the sonic hedgehog signaling pathway, notably the PTCH1 gene.
- Characterized by early-onset basal cell carcinomas and extracutaneous manifestations like odontogenic keratocysts and medulloblastoma.
Purpose of the Study:
- To summarize the key features of Gorlin syndrome.
- To discuss diagnostic and management challenges.
- To review emerging therapeutic strategies targeting the sonic hedgehog pathway.
Main Methods:
- Literature review of Gorlin syndrome.
- Analysis of clinical manifestations and genetic basis.
- Evaluation of current and novel treatment options.
Main Results:
- Gorlin syndrome presents with multiple basal cell carcinomas and other developmental abnormalities.
- Diagnosis requires a multidisciplinary approach.
- New sonic hedgehog pathway inhibitors offer potential but have limitations.
Conclusions:
- Gorlin syndrome necessitates comprehensive, multidisciplinary care.
- Targeted therapies for the sonic hedgehog pathway are evolving.
- Managing side effects and resistance remains critical for treatment efficacy.
More Related Videos
09:39Generation of Induced Pluripotent Stem Cells from Turner Syndrome 45XO Fetal Cells for Downstream Modelling of Neurological Deficits Associated with the Syndrome
Published on: December 4, 2021
05:12Portable Thermographic Screening for Detection of Acute Wallenberg's Syndrome
Published on: September 19, 2019
Related Concept Videos
01:24Nephrotic Syndrome I : Introduction
01:30Acute Coronary Syndrome I: Introduction
01:17Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
01:27Restless Leg Syndrome and Night Terrors
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
01:26Acute Coronary Syndrome V: Nursing Management
01:26Nephrotic Syndrome II : Assessment and Medical Management